Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM)

被引:74
作者
Garg, S
Anderson, RA
Chany, CJ
Waller, DP
Diao, XH
Vermani, K
Zaneveld, LJD
机构
[1] Rush Univ, Rush Presbyterian St Lukes Med Ctr, Sect Ob Gyn Res, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Pharmaceut & Pharmacodynam, Chicago, IL USA
关键词
formulation; bioadhesive; AIDS; sexually transmitted diseases; contraception;
D O I
10.1016/S0010-7824(01)00217-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Vaginal prophylactic methodology may prevent heterosexual transmission of the HIV and other sexually transmitted disease-causing organisms as well as unplanned pregnancies. A new delivery system (ACIDFORM) was designed with acid-buffering, bioadhesive, and viscosity-retaining properties to (1) maintain the acidic vaginal milieu (the low pH inactivates many pathogens and spermatozoa), (2) form a protective layer over the vaginal/cervical epithelium (minimizing contact with pathogenic organisms), and (3) provide long-term vaginal retention. A Phase I clinical study with ACIDFORM provided initial information about its safety and showed the formation of a layer over the vaginal/cervical epithelium [1; Amaral et al., Contraception 1999;60:361-6]. To study the properties of the gel (without active ingredient) in more detail, ACIDFORM's acid-buffering, bioadhesive, viscosity-retaining, and spermicidal properties were compared in vitro to marketed formulations, and its long-term stability was assessed. ACIDFORM, either when titrated with NaOH or when mixed directly with semen, is highly acid buffering and much more effective than Aci-Jel, a commercial acid-buffering vaginal product. ACIDFORM adheres well to two model membranes (excised sheep vagina and cellophane) and is more bioadhesive than Conceptrol, Advantage S, Replens, Aci-Jel, and K-Y jelly. On dilution, ACIDFORM also retains its viscosity better than these marketed products. ACIDFORM is spermicidal and is stable for at least 2 years. These results suggest that ACIDFORM has advantages over presently marketed vaginal delivery systems. The gel may either be useful by itself as an antimicrobial contraceptive product or as a formulation vehicle for an active ingredient with antimicrobial and/or contraceptive properties. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 41 条
[1]   Study of the vaginal tolerance to acidform, an acid-buffering, bioadhesive gel [J].
Amaral, E ;
Faúndes, A ;
Zaneveld, L ;
Waller, D ;
Garg, S .
CONTRACEPTION, 1999, 60 (06) :361-366
[2]   TREATMENT OF BACTERIAL VAGINOSIS WITH AN ACID CREAM - A COMPARISON BETWEEN THE EFFECT OF LACTATE-GEL AND METRONIDAZOLE [J].
ANDERSCH, B ;
FORSSMAN, L ;
LINCOLN, K ;
TORSTENSSON, P .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1986, 21 (01) :19-25
[3]  
Anderson RA, 2000, J ANDROL, V21, P862
[4]   Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process [J].
Bos, OJM ;
Sunyé, DGJ ;
Nieuweboer, CEF ;
van Engelenburg, FAC ;
Schuitemaker, H ;
Over, J .
BIOLOGICALS, 1998, 26 (04) :267-276
[5]  
BOURNE N, 1999, INT SOC SEX TRANSM D
[6]   Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy [J].
Brown, J ;
Hooper, G ;
Kenyon, CJ ;
Haines, S ;
Burt, J ;
Humphries, JM ;
Newman, SP ;
Davis, SS ;
Sparrow, RA ;
Wilding, IR .
PHARMACEUTICAL RESEARCH, 1997, 14 (08) :1073-1078
[7]  
CUUVIN S, MICR 2000 MARCH 13 1, P38
[8]   The AIDS epidemic - Considerations for the 21st century [J].
Fauci, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1046-1050
[9]  
GARG S, MICR 2000 MARCH 13 1, P41
[10]  
Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12